Amsurg (AMSG) Tops Q2 EPS by 13c, Raises FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Piper Jaffray Raises Price Target on Amsurg (AMSG) to $82 Following 2Q EPS Beat
August 5, 2015 9:47 AM EDTPiper Jaffray reiterated an Overweight rating on AmSurg (NASDAQ: AMSG), and raised the price target to $82.00 (from $72.00), following 2Q results. Revenues increased 131% y/y to $642M, which was $29M higher than consensus of $613M. Adjusted EPS of $0.97 was $0.13 higher than consensus of $0.84.
Analyst... More
